Defining Efficacy and Futility Criteria
Defining Efficacy and Futility Criteria How to Define Efficacy and Futility Criteria in Clinical Trials Introduction: Why Stopping Rules Matter Pre-specified stopping rules are critical safeguards in clinical trial design. They allow Data Monitoring Committees (DMCs) to recommend continuing, modifying, or terminating a study based on interim results. These rules rely on clearly defined efficacy…
